Opportunity status:
Upcoming
Funders:
Medical Research Council (MRC)
Funding type:
Grant
Publication date:
30 June 2026
Opening date:
30 July 2026 9:00am UK time
Closing date:
19 November 2026 4:00pm UK time
We are seeking director-led applications to investigate mechanistic biomedical drivers of obesity and related cardiometabolic disease and deliver transformative impact in obesity research.
The director, supported by a leadership team, will lead the design and delivery of a collaborative institute. Applications should focus on the key barriers to unlock understanding of the causes and consequences of obesity to enable targeted prevention and treatment.
The funding available is up to £60 million, and for seven years duration, with the potential to renew.
Funding of this opportunity is subject to approval of a full business case.
This is the most important predictor.
Competitive proposals closely match:
A scientifically excellent proposal that does not fit the published scope is unlikely to be funded.
UKRI evaluates whether the research:
Reviewers assess the originality, significance, and quality of the proposed research.
Competitive proposals typically demonstrate:
UKRI supports both curiosity-driven discovery research and innovative applied research, depending on the funding opportunity.
Applications should provide:
Reviewers expect a convincing plan for delivering the proposed work.
UKRI's assessment framework places strong emphasis on the ability of the applicant and team to deliver the project.
Competitive teams demonstrate:
For early-career schemes, reviewers evaluate potential rather than only past achievements.
Reviewers consider whether the research environment provides:
The host organization should clearly demonstrate its ability to support successful project delivery.
Although UKRI has moved away from the separate "Pathways to Impact" document, proposals are still expected to explain how the research could generate benefits.
Competitive applications describe potential impacts such as:
The expected impact should be appropriate to the research stage and funding opportunity.
UKRI increasingly encourages interdisciplinary research.
Competitive projects often involve:
Cross-sector collaboration is especially important for large strategic and challenge-led programs.
UKRI expects applicants to consider:
These considerations strengthen the overall quality and credibility of the proposal.
Reviewers assess whether:
Strong justification of resources is an important component of UKRI review.
This funding opportunity is open to organisations with standard eligibility. Check if your organisation is eligible.
Who is eligible to apply
The nominated director (project lead) should lead the application, alongside a leadership team, and with the full support of their host research organisations.
To be eligible to apply for UK Obesity Research Institute (UK-ORI) funding, you must:
For applicants who do not have a contract of employment for the duration of the proposed project, by submitting an application the research organisation is confirming that, if it is successful:
Demand management
An eligible research organisation may lead one application only but is allowed to be a co-lead, or collaborate, on other applications.
Who is not eligible to apply
If you are employed by the following organisations, you cannot apply as project lead or project co-lead but can participate as project partners on an application led by an eligible UK organisation:
International researchers
International organisations cannot lead an application as part of the leadership team or lead one of the UK research sites. International researchers are permitted as a project co-lead (international) if making an important research contribution to one of the UK sites.
We would expect co-leads based outside the UK to offer expertise, or facilities not available in the UK, and to provide clear indicators of commitment to the UK-ORI. The contribution and added value of the international participants to the research collaboration should be clearly explained and justified in the application.
Read the UKRI project co-lead (international) eligibility for more details. Please contact us if you are uncertain about eligibility. See the ‘Contact details’ section.
You should include all other international collaborators (or UK partners not based at approved organisations) as project partners.
Equality, diversity, and inclusion
We are committed to achieving equality of opportunity for all funding applicants. We encourage applications from a diverse range of researchers.
We support people to work in a way that suits their personal circumstances. This includes:
UKRI can offer disability and accessibility support for UK Research and Innovation (UKRI) applicants and grant holders during the application and assessment process.
Eligible Countries:
Sponsor Institute/Organizations: UK Research and Innovation
Sponsor Type: Corporate/Non-Profit
Address: Polaris House, North Star Avenue, Swindon SN2 1FL
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Nov 19, 2026
Nov 19, 2026
Varies
varies
Affiliation: UK Research and Innovation
Address: Polaris House, North Star Avenue, Swindon SN2 1FL
Website URL: https://www.ukri.org/opportunity/uk-obesity-research-institute/
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.